chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain in extremity, Salivary hypersecretion, Tenderness
Clinical narrative: BRUISE ON SHIN; HIT SHIN ON CAR; LOWER BACK PAIN; EXTRA SALIVA PRODUCTION; LETHARGY; HOT AND COLD SWEATS; TENDERNESS; ARM PAIN; BAD COLD; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bad cold. On 07-APR-2021, the subject experienced lethargy. On 07-APR-2021, the subject experienced hot and cold sweats. On 07-APR-2021, the subject experienced tenderness. On 07-APR-2021, the subject experienced arm pain. Treatment medications included: paracetamol. On 08-APR-2021, the subject experienced extra saliva production. On 11-APR-2021, the subject experienced lower back pain. On 12-APR-2021, the subject experienced bruise on shin. On 12-APR-2021, the subject experienced hit shin on car. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extra saliva production, hot and cold sweats, and tenderness on APR-2021, and arm pain on 11-APR-2021, had not recovered from lower back pain, lethargy, bruise on shin, and hit shin on car, and the outcome of bad cold was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Fatigue, Headache, Hypertension
Clinical narrative: ELEVATED BLOOD PRESSURE; SEVERE HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-APR-2021, the subject experienced severe headache. On 10-APR-2021, the subject experienced fatigue. On 12-APR-2021, the subject experienced elevated blood pressure. Laboratory data included: On 12/Apr/2021, computerized tomography scan was done to rule out blood clots. computerized tomography scan (CT scan) (NR: not provided) normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe headache, elevated blood pressure, and fatigue. This report was non-serious.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: DIZZINESS; HEADACHE ON LEFT SIDE OF FACE; This spontaneous report received from a patient concerned a 61 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-MAR-2021, the subject experienced dizziness. On 19-MAR-2021, the subject experienced headache on left side of face. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and headache on left side of face. This report was non-serious.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Petechiae
Clinical narrative: TINY RED DOTS ALL OVER FACE MOSTLY ON EYELIDS AND CHEEKS/PETECHIAE; HEADACHES; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 09-JUN-2021) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced tiny red dots all over face mostly on eyelids and cheeks/petechiae. On MAR-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headaches and tiny red dots all over face mostly on eyelids and cheeks/petechiae was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Nausea, Pain, Pruritus
Clinical narrative: DIFFICULTY SLEEPING; NAUSEA; HEADACHE; RASH; ITCHING; PAIN; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol use, and nonsmoker, and other pre-existing medical conditions included the patient had drug allergies and had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with amoxicillin, and hydromorphone hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced rash. On 05-APR-2021, the subject experienced itching. On 05-APR-2021, the subject experienced pain. On 10-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced nausea. On an unspecified date, the subject experienced difficulty sleeping. Treatment medications (dates unspecified) included: cortisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching, headache, rash, pain, and difficulty sleeping, and the outcome of nausea was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: DIFFICULTY SLEEPING; NAUSEA; HEADACHE; RASH; ITCHING; PAIN; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol use, and nonsmoker, and other pre-existing medical conditions included the patient had drug allergies and had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with amoxicillin, and hydromorphone hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced rash. On 05-APR-2021, the subject experienced itching. On 05-APR-2021, the subject experienced pain. On 10-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced nausea. On an unspecified date, the subject experienced difficulty sleeping. Treatment medications (dates unspecified) included: cortisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching, headache, rash, pain, and difficulty sleeping, and the outcome of nausea was not reported. This report was non-serious.
Age: 31.0
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Injection site pain, Pain in extremity, Pyrexia
Clinical narrative: PAIN IN ARM; ANXIETY ABOUT BLOOD CLOTS; FEVER; INJECTION SITE SORENESS; This spontaneous report received from a consumer concerned a 31 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced injection site soreness. On 10-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced anxiety about blood clots. On 13-APR-2021, the subject experienced pain in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 11-APR-2021, was recovering from injection site soreness, and had not recovered from pain in arm, and anxiety about blood clots. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Pain
Clinical narrative: DIZZINESS; HEADACHE; FEVER; TIREDNESS; SHAKING; GENERALISED ACHING; CHILLS; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid 19, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 17:20 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced generalised aching. On 11-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced shaking. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced tiredness. On 13-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 14-APR-2021, and was recovering from generalised aching, chills, fever, shaking, tiredness, and dizziness. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: DIZZINESS; HEADACHE; FEVER; TIREDNESS; SHAKING; GENERALISED ACHING; CHILLS; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid 19, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 17:20 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced generalised aching. On 11-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced shaking. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced tiredness. On 13-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 14-APR-2021, and was recovering from generalised aching, chills, fever, shaking, tiredness, and dizziness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: EXTREME FATIGUE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced extreme fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from extreme fatigue. This report was non-serious.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pyrexia
Clinical narrative: DIZZINESS; NAUSEA; FEVER; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's past medical history included vertigo, and autonomic dysfunction, and concurrent conditions included sulfa allergy, iodine allergy, perennial allergy, and food allergy, and other pre-existing medical conditions included history of vertigo and automatic dysfunction and allergic to sulfa, iodine, perennial and food. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced dizziness. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, and fever on 07-APR-2021, and was recovering from nausea. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: LEG PAIN; This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced leg pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of leg pain was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations
Clinical narrative: RACING HEART FEELINGS; SLIGHT PAIN IN LEG; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced racing heart feelings, and slight pain in leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight pain in leg and racing heart feelings was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Lymphadenopathy, Pyrexia
Clinical narrative: HARD TIME SLEEPING; LEFT LYMPH SWELLING; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced hard time sleeping. On APR-2021, the subject experienced left lymph swelling. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on APR-2021, and had not recovered from headache, hard time sleeping, and left lymph swelling. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: INCESSANT RINGING IN EARS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced incessant ringing in ears. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from incessant ringing in ears. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: BRUISED INJECTION SITE  / BRUISED RIGHT ARM; LEG PAIN; This spontaneous report received from a consumer concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included congestive heart failure, type 2 diabetes, abstain from alcohol, non-smoker, and unspecified allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 05-APR-2021, the subject experienced bruised injection site / bruised right arm. On 05-APR-2021, the subject experienced leg pain. Treatment medications (dates unspecified) included: menthol, and emu oil/trolamine salicylate. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from leg pain, and bruised injection site / bruised right arm. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect product administration duration
Clinical narrative: PRODUCT ADMINISTERED  2-6 MINUTES BEYOND USE TIME OF 2 HRS; This spontaneous report received from a physician concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced product administered 2-6 minutes beyond use time of 2 hrs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of product administered 2-6 minutes beyond use time of 2 hrs was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: FEELING A HEART ATTACK COMING ON; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced feeling a heart attack coming on. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of feeling a heart attack coming on was not reported. This report was non-serious.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Back pain, Bone pain, Disturbance in attention
Clinical narrative: RIGHT SHIN PAIN; ANXIETY; DIFFICULTY CONCENTRATING; HEAD FELLS FUZZY; POTENTIAL SHINGLES; SEVERE LEG PAIN IN RIGHT LEG/RIGHT THIGH PAIN; RIGHT HIP PAIN/RIGHT ANKLE PAIN; LOWER AND MID BACK PAIN; SENSATION IN HEAD AND NECK; This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included inflammation, blood pressure, abstains from alcohol, and smoker (1 pack/day or a little less), and other pre-existing medical conditions included the patient had no known allergies and there was no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: 13/JUN/2021) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. Concomitant medications included chlortalidone for blood pressure high, and ibuprofen for inflammation. On 26-MAR-2021, the subject experienced sensation in head and neck. On 27-MAR-2021, the subject experienced right hip pain/right ankle pain. On 27-MAR-2021, the subject experienced lower and mid back pain. On an unspecified date, the subject experienced right shin pain, anxiety, difficulty concentrating, head fells fuzzy, potential shingles, and severe leg pain in right leg/right thigh pain. Laboratory data (dates unspecified) included: Platelet count (NR: not provided) 271 (units unspecified). Treatment medications (dates unspecified) included: cefalexin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe leg pain in right leg/right thigh pain, right shin pain, difficulty concentrating, head fells fuzzy, and lower and mid back pain, and the outcome of sensation in head and neck, right hip pain/right ankle pain, anxiety and potential shingles was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Herpes zoster, Pain in extremity, Platelet count, Sensory disturbance
Clinical narrative: RIGHT SHIN PAIN; ANXIETY; DIFFICULTY CONCENTRATING; HEAD FELLS FUZZY; POTENTIAL SHINGLES; SEVERE LEG PAIN IN RIGHT LEG/RIGHT THIGH PAIN; RIGHT HIP PAIN/RIGHT ANKLE PAIN; LOWER AND MID BACK PAIN; SENSATION IN HEAD AND NECK; This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included inflammation, blood pressure, abstains from alcohol, and smoker (1 pack/day or a little less), and other pre-existing medical conditions included the patient had no known allergies and there was no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: 13/JUN/2021) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. Concomitant medications included chlortalidone for blood pressure high, and ibuprofen for inflammation. On 26-MAR-2021, the subject experienced sensation in head and neck. On 27-MAR-2021, the subject experienced right hip pain/right ankle pain. On 27-MAR-2021, the subject experienced lower and mid back pain. On an unspecified date, the subject experienced right shin pain, anxiety, difficulty concentrating, head fells fuzzy, potential shingles, and severe leg pain in right leg/right thigh pain. Laboratory data (dates unspecified) included: Platelet count (NR: not provided) 271 (units unspecified). Treatment medications (dates unspecified) included: cefalexin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe leg pain in right leg/right thigh pain, right shin pain, difficulty concentrating, head fells fuzzy, and lower and mid back pain, and the outcome of sensation in head and neck, right hip pain/right ankle pain, anxiety and potential shingles was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Product storage error
Clinical narrative: SIDE EFFECTS; STORAGE ISSUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced side effects, storage issue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the side effects, storage issue was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Malaise, Nausea
Clinical narrative: ILL; HEADACHE; NAUSEA; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced ill, headache, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, nausea and ill was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Heart rate increased
Clinical narrative: DIFFICULTY BREATHING; FAST HEART BEAT; DIZZINESS; WEAKNESS; This spontaneous report received from a patient concerned a 28 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and  expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced difficulty breathing. On 10-APR-2021, the subject experienced fast heart beat. On 10-APR-2021, the subject experienced dizziness. On 10-APR-2021, the subject experienced weakness.  Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from difficulty breathing, fast heart beat, dizziness, and weakness. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperaesthesia, Illness
Clinical narrative: COULD NOT HAD ANYTHING TOUCH ENTIRE ARM; SICK; CHILLS; FEVER; HEADACHE; FATIGUE; ACHING MUSCLE; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced could not had anything touch entire arm. On APR-2021, the subject experienced sick. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced aching muscle. On APR-2021, the subject experienced the injection hurts extremely bad and was swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, fatigue, aching muscle, the injection hurts extremely bad and was swollen, the injection hurts extremely bad and was swollen, could not had anything touch entire arm, and sick. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Myalgia, Pyrexia
Clinical narrative: COULD NOT HAD ANYTHING TOUCH ENTIRE ARM; SICK; CHILLS; FEVER; HEADACHE; FATIGUE; ACHING MUSCLE; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced could not had anything touch entire arm. On APR-2021, the subject experienced sick. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced aching muscle. On APR-2021, the subject experienced the injection hurts extremely bad and was swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, fatigue, aching muscle, the injection hurts extremely bad and was swollen, the injection hurts extremely bad and was swollen, could not had anything touch entire arm, and sick. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Headache, Vision blurred
Clinical narrative: BLURRY VISION; PAIN IN EYES; HEADACHE; This spontaneous report received from a patient concerned a 41 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 11-APR-2021, the subject experienced blurry vision. On 11-APR-2021, the subject experienced pain in eyes. On 11-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, blurry vision, and pain in eyes. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: LIGHT-HEADED; DIZZINESS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced light-headed. On APR-2021, the subject experienced dizziness. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from light-headed, dizziness, headache, and nausea. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: LITTLE SORE ARM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 2021, the subject experienced little sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of little sore arm was not reported. This report was non-serious.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Dizziness, Limb discomfort, Migraine
Clinical narrative: TRANSIENT DIZZINESS AND LIGHT HEADED; STOMACH PAIN; SWOLLEN LEGS; LEG PAIN; MIGRAINES /MIGRAINE TYPE HEADACHE TOWARDS  RIGHT EYE; HEAVY LEGS; RASH ON BOTH LEGS; DIARRHEA; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, and non smoker, and other pre-existing medical conditions included no medical history. The patient had no known allergies and no drug abuse or illicit drug usage.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042821A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced diarrhea. On APR-2021, the subject experienced rash on both legs. On 06-APR-2021, the subject experienced migraines /migraine type headache towards right eye. On 06-APR-2021, the subject experienced heavy legs. On 12-APR-2021, the subject experienced stomach pain. On 12-APR-2021, the subject experienced swollen legs. On 12-APR-2021, the subject experienced leg pain. On 15-APR-2021, the subject experienced transient dizziness and light headed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraines /migraine type headache towards right eye, stomach pain, and swollen legs on APR-2021, had not recovered from rash on both legs, leg pain, transient dizziness and light headed, and heavy legs, and the outcome of diarrhea was not reported. This report was non-serious.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Rash
Clinical narrative: TRANSIENT DIZZINESS AND LIGHT HEADED; STOMACH PAIN; SWOLLEN LEGS; LEG PAIN; MIGRAINES /MIGRAINE TYPE HEADACHE TOWARDS  RIGHT EYE; HEAVY LEGS; RASH ON BOTH LEGS; DIARRHEA; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, and non smoker, and other pre-existing medical conditions included no medical history. The patient had no known allergies and no drug abuse or illicit drug usage.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042821A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced diarrhea. On APR-2021, the subject experienced rash on both legs. On 06-APR-2021, the subject experienced migraines /migraine type headache towards right eye. On 06-APR-2021, the subject experienced heavy legs. On 12-APR-2021, the subject experienced stomach pain. On 12-APR-2021, the subject experienced swollen legs. On 12-APR-2021, the subject experienced leg pain. On 15-APR-2021, the subject experienced transient dizziness and light headed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraines /migraine type headache towards right eye, stomach pain, and swollen legs on APR-2021, had not recovered from rash on both legs, leg pain, transient dizziness and light headed, and heavy legs, and the outcome of diarrhea was not reported. This report was non-serious.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear discomfort, Full blood count, Heavy menstrual bleeding, Hot flush
Clinical narrative: EAR PRESSURE; HEAVY PERIOD FIRST DAY; HOT FLASH ON FACE; SINUS PRESSURE; CHILLS; This spontaneous report received from a patient concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroid, and graves disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine for hypothyroid.  On APR-2021, Laboratory data included: CBC (NR: not provided) Good, Liver function test (NR: not provided) Good, and Pregnancy test (NR: not provided) Good. On 09-APR-2021, the subject experienced ear pressure. On 09-APR-2021, the subject experienced heavy period first day. On 09-APR-2021, the subject experienced hot flash on face. On 09-APR-2021, the subject experienced sinus pressure. On 09-APR-2021, the subject experienced chills. Treatment medications (dates unspecified) included: cetirizine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heavy period first day on 09-APR-2021, and sinus pressure on 14-APR-2021, was recovering from ear pressure, and hot flash on face, and had not recovered from chills. This report was non-serious.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Liver function test, Paranasal sinus discomfort, Pregnancy test
Clinical narrative: EAR PRESSURE; HEAVY PERIOD FIRST DAY; HOT FLASH ON FACE; SINUS PRESSURE; CHILLS; This spontaneous report received from a patient concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroid, and graves disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine for hypothyroid.  On APR-2021, Laboratory data included: CBC (NR: not provided) Good, Liver function test (NR: not provided) Good, and Pregnancy test (NR: not provided) Good. On 09-APR-2021, the subject experienced ear pressure. On 09-APR-2021, the subject experienced heavy period first day. On 09-APR-2021, the subject experienced hot flash on face. On 09-APR-2021, the subject experienced sinus pressure. On 09-APR-2021, the subject experienced chills. Treatment medications (dates unspecified) included: cetirizine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heavy period first day on 09-APR-2021, and sinus pressure on 14-APR-2021, was recovering from ear pressure, and hot flash on face, and had not recovered from chills. This report was non-serious.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blister, Body temperature, Cough, Diarrhoea
Clinical narrative: SKIN PEELING; SKIN BLISTER; RASH UNDER BREAST; HEADACHE; STOMACH PAIN; DIARRHEA; COUGH; BODY ACHES; FEVER; This spontaneous report received from a patient concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 10-APR-2021 12:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced cough. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced fever. Laboratory data included: Fever (NR: not provided) 100.7 F. Treatment medications included: guaifenesin, and paracetamol. On 11-APR-2021, the subject experienced stomach pain. On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced skin peeling. On 14-APR-2021, the subject experienced skin blister. On 14-APR-2021, the subject experienced rash under breast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, cough, body aches, headache, stomach pain, and diarrhea, and had not recovered from rash under breast, skin peeling, and skin blister. This report was non-serious.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Rash, Skin exfoliation
Clinical narrative: SKIN PEELING; SKIN BLISTER; RASH UNDER BREAST; HEADACHE; STOMACH PAIN; DIARRHEA; COUGH; BODY ACHES; FEVER; This spontaneous report received from a patient concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 10-APR-2021 12:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced cough. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced fever. Laboratory data included: Fever (NR: not provided) 100.7 F. Treatment medications included: guaifenesin, and paracetamol. On 11-APR-2021, the subject experienced stomach pain. On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced skin peeling. On 14-APR-2021, the subject experienced skin blister. On 14-APR-2021, the subject experienced rash under breast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, cough, body aches, headache, stomach pain, and diarrhea, and had not recovered from rash under breast, skin peeling, and skin blister. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEAD HURTS UNTIL AT THE BACK OF SKULL; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced head hurts until at the back of skull. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from head hurts until at the back of skull. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Joint swelling, Swelling face, Vomiting
Clinical narrative: THROWING UP; FACE BLEW UP; JOINTS SWOLLEN UP; VIOLENT HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced throwing up. On 09-APR-2021, the subject experienced face blew up. On 09-APR-2021, the subject experienced joints swollen up. On 09-APR-2021, the subject experienced violent headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the violent headache, throwing up, joints swollen up and face blew up was not reported. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Influenza like illness, Injection site pain, Malaise, Pain in extremity
Clinical narrative: SORENESS IN  ARM (BACK SIDE OF LEFT ARM) AND ACHE IN THE ARM; INJECTION SITE SORENESS; ON AND OFF FLU LIKE SYMPTOMS; HOT FLASHES; FEELING SICK; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's concurrent conditions included menopause, and cigarette smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the drug abuse or illicit drug usage was unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination.  Concomitant medications included sertraline hydrochloride.  On MAR-2021, the subject experienced feeling sick. On 25-MAR-2021, the subject experienced on and off flu like symptoms. On 25-MAR-2021, the subject experienced hot flashes. On 25-MAR-2021, the subject experienced injection site soreness. On 02-APR-2021, the subject experienced soreness in arm (back side of left arm) and ache in the arm. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling sick, and injection site soreness, was recovering from on and off flu like symptoms, had not recovered from soreness in arm (back side of left arm) and ache in the arm, and the outcome of hot flashes was not reported. This report was non-serious.